BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1708890)

  • 1. Thymic tumorigenesis induced by overexpression of p56lck.
    Abraham KM; Levin SD; Marth JD; Forbush KA; Perlmutter RM
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3977-81. PubMed ID: 1708890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed thymocyte development induced by augmented expression of p56lck.
    Abraham KM; Levin SD; Marth JD; Forbush KA; Perlmutter RM
    J Exp Med; 1991 Jun; 173(6):1421-32. PubMed ID: 1709675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of thymocyte development and lymphomagenesis induced by SV40 T-antigen.
    Garvin AM; Abraham KM; Forbush KA; Farr AG; Davison BL; Perlmutter RM
    Int Immunol; 1990; 2(2):173-80. PubMed ID: 1965144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased signaling competence as a result of receptor overexpression: overexpression of CD4 reduces its ability to activate p56lck tyrosine kinase and to regulate T-cell antigen receptor expression in immature CD4+CD8+ thymocytes.
    Nakayama T; Wiest DL; Abraham KM; Munitz TI; Perlmutter RM; Singer A
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10534-8. PubMed ID: 7902564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement for tyrosine kinase p56lck for thymic development of transgenic gamma delta T cells.
    Penninger J; Kishihara K; Molina T; Wallace VA; Timms E; Hedrick SM; Mak TW
    Science; 1993 Apr; 260(5106):358-61. PubMed ID: 8469988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p56lck signals for regulating thymocyte development can be distinguished by their dependency on Rho function.
    Henning SW; Cantrell DA
    J Exp Med; 1998 Sep; 188(5):931-9. PubMed ID: 9730894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of interleukin 2-responsiveness in thymocytes of the transgenic mice carrying lck-transgene.
    Moroi Y; Koga Y; Nakamura K; Ohtsu M; Kimura G; Nomoto K
    Microbiol Immunol; 1993; 37(5):369-81. PubMed ID: 8102775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck.
    Abraham N; Miceli MC; Parnes JR; Veillette A
    Nature; 1991 Mar; 350(6313):62-6. PubMed ID: 1706070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and characterization of transforming variants of the lck tyrosine protein kinase.
    Adler HT; Sefton BM
    Oncogene; 1992 Jun; 7(6):1191-9. PubMed ID: 1594248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An activated lck transgene promotes thymocyte development in RAG-1 mutant mice.
    Mombaerts P; Anderson SJ; Perlmutter RM; Mak TW; Tonegawa S
    Immunity; 1994 Jul; 1(4):261-7. PubMed ID: 7889413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-linking of T-cell surface molecules CD4 and CD8 stimulates phosphorylation of the lck tyrosine protein kinase at the autophosphorylation site.
    Luo KX; Sefton BM
    Mol Cell Biol; 1990 Oct; 10(10):5305-13. PubMed ID: 2118992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coclustering CD45 with CD4 or CD8 alters the phosphorylation and kinase activity of p56lck.
    Ostergaard HL; Trowbridge IS
    J Exp Med; 1990 Jul; 172(1):347-50. PubMed ID: 2141630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins.
    Peri KG; Gervais FG; Weil R; Davidson D; Gish GD; Veillette A
    Oncogene; 1993 Oct; 8(10):2765-72. PubMed ID: 7690927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lymphocyte-specific tyrosine protein kinase p56lck.
    Abraham N; Veillette A
    Cancer Invest; 1991; 9(4):455-63. PubMed ID: 1832077
    [No Abstract]   [Full Text] [Related]  

  • 15. The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex.
    Barber EK; Dasgupta JD; Schlossman SF; Trevillyan JM; Rudd CE
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3277-81. PubMed ID: 2470098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible expression of a p56Lck transgene reveals a central role for Lck in the differentiation of CD4 SP thymocytes.
    Legname G; Seddon B; Lovatt M; Tomlinson P; Sarner N; Tolaini M; Williams K; Norton T; Kioussis D; Zamoyska R
    Immunity; 2000 May; 12(5):537-46. PubMed ID: 10843386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs.
    Turner JM; Brodsky MH; Irving BA; Levin SD; Perlmutter RM; Littman DR
    Cell; 1990 Mar; 60(5):755-65. PubMed ID: 2107025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of thymic development in an Lck(-/-) thymoma overexpressing ZAP-70.
    Ulivieri C; Majolini MB; Baldari CT
    Mol Immunol; 2000; 37(1-2):85-90. PubMed ID: 10781838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protein tyrosine kinase p56lck regulates thymocyte development independently of its interaction with CD4 and CD8 coreceptors [corrected].
    Levin SD; Abraham KM; Anderson SJ; Forbush KA; Perlmutter RM
    J Exp Med; 1993 Jul; 178(1):245-55. PubMed ID: 8391060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the enzymatic function of the lymphocyte-specific tyrosine protein kinase p56lck by the non-catalytic SH2 and SH3 domains.
    Veillette A; Caron L; Fournel M; Pawson T
    Oncogene; 1992 May; 7(5):971-80. PubMed ID: 1570157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.